GE HealthCare imaging CEO Jan Makela talks Mayo Clinic partnership

GE and Mayo Clinic plan to collaborate on imaging, artificial intelligence and cancer treatment.

By Elise Reuter • Oct. 6, 2023

Bigfoot CEO talks Abbott acquisition, future of diabetes tech

Jeffrey Brewer hopes to see more integrated solutions for people with diabetes, starting with the company’s partnership with Abbott.

By Elise Reuter • Sept. 15, 2023

Intuitive’s Tony Jarc on how AI is improving robotic surgery

The company aims to help surgeons achieve better results for patients and hospitals.

By Susan Kelly • Sept. 8, 2023

ZimVie’s Rebecca Whitney sizes up the competition in cervical disc implants

The company is bringing new products to market as it faces more challengers in cervical disc replacement and tethering for scoliosis.

By Elise Reuter • Sept. 1, 2023

Q&A: ‘Chaotic’ digital health market needs independent evaluation, new institute says

Independent evaluation could help the healthcare industry figure out which digital health products are backed by evidence, argues Caroline Pearson, executive director of the nonprofit Peterson Center on Healthcare.

By Emily Olsen • Aug. 11, 2023

Q&A: How Monogram’s CEO plans to disrupt robotic joint replacement surgery

The robot developer’s CEO, Benjamin Sexson, tells MedTech Dive why he believes the orthopedics market needs a fresh approach to joint reconstruction.

By Susan Kelly • Aug. 4, 2023

Q&A: Penumbra CEO Adam Elsesser says new devices will drive changes in clot treatment

Penumbra has launched two devices that use computers to control suction of blood clots. That’s helped the company convert some surgeons from traditional methods of clot removal, like open surgery or drugs.

By Elise Reuter • July 7, 2023

Q&A: Dexcom’s Lawver shares strategy behind CGM for non-insulin users

The continuous glucose monitor in development for people with Type 2 diabetes who don’t take insulin could expand the CGM market to 25 million more people in the U.S., the company’s new chief commercial officer said.

By Elise Reuter • June 30, 2023

BD tech chief Beth McCombs talks about Parata acquisition, automation

As pharmacies and labs face cost pressures and staffing shortages, automation offers a way to save scarce healthcare dollars, McCombs says.

By Elise Reuter • June 16, 2023

Friday Q&A: Biosense Webster’s Brooks and Hong talk about cardiac ablation

The leaders of Johnson & Johnson’s Biosense Webster unit see growth opportunities with new cardiac ablation technologies, despite a crowded field that includes Abbott, Boston Scientific and Medtronic.

By Elise Reuter • June 9, 2023

How they built it: Florian Hillen wants to look at your teeth with his AI

Hillen is building a business on the premise that using artificial intelligence to examine dental X-rays can nearly double diagnostic accuracy, and help detect other diseases.

By Peter Green • June 7, 2023

Friday Q&A: Stanford Biodesign’s Makower on expediting Medicare coverage for breakthrough devices

The director and co-founder of the Stanford Byers Center for Biodesign has been urging CMS to get patients access to breakthrough devices.

By Susan Kelly • Updated May 26, 2023

Friday Q&A: Boston Scientific’s De Rosa on the rise of an AFib ‘game changer’

The Switzerland-based vice president of rhythm management for Europe, the Middle East and Africa expects a “massive shift” to pulsed field ablation from other atrial fibrillation treatments.

By Susan Kelly • May 5, 2023

Friday Q&A: J&J’s Shan Jegatheeswaran talks about the ‘behind the scenes’ work of AI in medtech

The global head of digital solutions for J&J’s medtech unit says the intersection between software and how it’s used is an important, and often overlooked, aspect of AI.

By Elise Reuter • April 28, 2023

Friday Q&A: Abbott’s Vish Charan on muscling into the leadless pacemaker market

Abbott is taking on Medtronic in the market for wireless devices to treat abnormally slow heart rhythms.

By Susan Kelly • April 21, 2023

Friday Q&A: Medtronic’s Ajizian talks connected care ahead of unit spinoff

From supporting AI-driven medical interventions to freeing up providers from administrative tasks, remote patient monitoring is raising the bar for care, says Medtronic’s CMO for patient monitoring.

By Susan Kelly • April 15, 2023

Friday Q&A: Movano takes on the women’s wearables market with a smart ring

Movano Health aims to stand out from the wearables crowd with a women’s health focus and strategy that is centered on obtaining FDA clearances.

By Susan Kelly • March 24, 2023

Friday Q&A: A startup founder tackles the riddle of why we cough

Joe Brew, the founder of three-year-old Hyfe, sees the potential for cough-tracking technology to be as ubiquitous as blood-pressure cuffs.

By Susan Kelly • March 17, 2023

Friday Q&A: A regulatory attorney breaks down the EU MDR transition

Amsterdam-based regulatory expert Erik Vollebregt explains the agreement this week to extend the deadlines to comply with the EU’s Medical Device Regulation, and the issues that still need to be addressed.

By Susan Kelly • March 10, 2023

Friday Q&A: GE HealthCare’s Yoder on using AI to drive precision care

The healthcare technology and diagnostics firm, now a standalone company, will integrate the acquisition of AI software developer Caption Health under Yoder’s lead.

By Susan Kelly • Feb. 23, 2023

Friday Q&A: Medtronic’s Chan talks patient monitoring spinoff, rise of home care

As more patients are moved out of expensive hospital beds, Medtronic sees a growing market for remote care in homes and long-term care facilities.

By Elise Reuter • Feb. 2, 2023

Friday Q&A: For GE HealthCare, the future is digital, CEO Arduini says

Digital capabilities will be “the next big inflection” driving growth for GE’s newly independent healthcare business. 

By Peter Green • Jan. 6, 2023

Freenome CEO Mike Nolan talks colorectal cancer test, clinical trials

The San Francisco-based company recently enrolled a clinical trial for its blood-based cancer test but faces competition in the market for minimally invasive cancer tests. 

By Elise Reuter • Dec. 22, 2022

The 10 biggest medtech stories of 2022

MedTech Dive reporting this year has explored how companies maintained momentum even amid supply shortages and rising inflation rates.

By MedTech Dive staff • Dec. 3, 2022

MedTech Innovators: Tissium co-founder Maria Pereira on taking tech from bench to bedside

The MIT-trained scientist explains how she went from PhD candidate to startup founder whose company is preparing to commercialize a range of products for use in reconstructing damaged tissue.

By Susan Kelly • Nov. 30, 2022